This may have been due to induced IL-10 release, which might have been counter-acted by simultaneous signaling modulation (60,61)

This may have been due to induced IL-10 release, which might have been counter-acted by simultaneous signaling modulation (60,61). identification of molecular mechanisms and signaling events that drive myeloid immune suppression in human tumors, more effective DC-targeted malignancy vaccines may be designed. Keywords:dendritic cells, human DC subsets, skin, macrophages, cancer, immune suppression == Dendritic Cell Subsets and Their Plasticity in Human Skin: Impact on Malignancy Vaccination == Skin is the largest human organ and its direct contact with the outside environment requires tightly regulated surveillance mechanisms to keep potentially harmful intruders at bay. For this purpose, human skin is usually densely populated with patrolling myeloid cells, such as Langerhans cells (LC) in the epidermal outer layer and various dermal dendritic cell (DDC) subsets and macrophages in the dermal layer (1,2). It has been elegantly shown that different profiles of pattern acknowledgement receptors present on the various myeloid subsets lining the skin makes them exquisitely specific in the acknowledgement, uptake and either direct removal of pathogenic microbes, or in presentation of pathogen-associated antigens for subsequent activation of the adaptive immune system ENPEP (35). Interaction of a pathogen with pathogen-recognition receptors on dendritic cell (DC) induces activation of down-stream signaling pathways that result in their enhanced ability to process and present pathogenic antigens and 4-Azido-L-phenylalanine in their migration to the draining lymph nodes, accompanied by phenotypic and morphological maturation, and priming of antigen-specific T or B lymphocytes (6). Whereas in the beginning studies concerning DC subsets in human skin mostly involved 4-Azido-L-phenylalanine the most predominant subsets, i.e., CD1ahiLangerin+LC, CD1a+DDC, and CD14+CD1aDDC (79), the characterization of new surface markers and deeper phenotypic and functional analyses now show that further distinctions can be made (1013). From our own work and that of others, it has become obvious that beside epidermal LC and dermal macrophages at least five migratory DDC subsets can be distinguished (13,14), i.e., CD1a+CD14DDC, CD1a+CD14+DDC, CD1aCD14+DDC, and two double-negative subsets. An important issue that as yet remains unresolved is usually whether all these 4-Azido-L-phenylalanine DC populations symbolize genuine subsets, or whether they are part of the same DC subset in various says of activation or differentiation. A growing number of studies now point to the presence of an inter-related populace of cutaneous DC and macrophages in flux, trans-differentiating into each other as directed by environmental cues (8,15,16). This has direct consequences for the type of 4-Azido-L-phenylalanine immune responses that will ensue, as different migratory DC sub-populations have now been directly linked to the induction of different types of immunity (13,14) and have different capacities to cross-present antigens for the activation of cytotoxic CD8 T cells, a process 4-Azido-L-phenylalanine crucial for the induction of anti-tumor immunity. Roughly, CD1a+mature LC and DDC subsets have been linked to type-1 T cell mediated immunity, whereas CD14+immature DDC subsets have been linked to the induction of humoral immunity and growth of regulatory T cells (Treg) (11,12); observe Physique1for a schematic overview. Recent evidence suggests that tumors like melanoma abuse the balance between these subsets to effectively escape immune acknowledgement (13,17). In order for DC-targeted vaccines delivered through the skin to be effective, tumor-induced immune suppression should be overcome and T cell-stimulatory DC subsets selectively targeted. Here, we discuss mechanisms of tumor-imposed DC suppression in the skin microenvironment and how these may be counter-acted in aid of DC-based immunotherapy. == Physique 1. == Overview of the reported T cell differentiation induction abilities of mature Langerhans cells (LC) and CD1a+dermal dendritic cells (DDC) vs. immature CD14+DDC. Abbreviations: DDC, dermal dendritic cell; IL, interleukin; LC, Langerhans cell; Th, T helper cell; Tfh, T follicular helper cell; Treg, T regulatory cell; TGF-, transforming growth factor . == LC and CD1a+DDC: T Cell Activation == Klechevsky et al. first explained a functional dichotomy between human LC and CD14+DDC.